Segments of Business and Geographic Areas - Sales By Segment Of Business (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Sales by segment of business
Sales to customers	$ 21,351	$ 19,996	$ 63,764	$ 60,051
Percent Change (as a percent)	6.80%		6.20%
U.S.
Sales by segment of business
Sales to customers	$ 11,996	10,794	$ 34,435	31,161
Percent Change (as a percent)	11.10%		10.50%
International
Sales by segment of business
Sales to customers	$ 9,355	9,202	$ 29,329	28,890
Percent Change (as a percent)	1.60%		1.50%
MEDTECH
Sales by segment of business
Sales to customers	$ 7,458	6,782	$ 22,727	20,651
Percent Change (as a percent)	10.00%		10.00%
MEDTECH | U.S.
Sales by segment of business
Sales to customers	$ 3,747	3,356	$ 11,345	9,932
Percent Change (as a percent)	11.60%		14.20%
MEDTECH | International
Sales by segment of business
Sales to customers	$ 3,711	3,426	$ 11,382	10,719
Percent Change (as a percent)	8.30%		6.20%
MEDTECH | Interventional Solutions
Sales by segment of business
Sales to customers	$ 1,558	1,060	$ 4,681	3,202
Percent Change (as a percent)	47.00%		46.20%
MEDTECH | Interventional Solutions | U.S.
Sales by segment of business
Sales to customers	$ 891	547	$ 2,662	1,566
Percent Change (as a percent)	63.00%		70.00%
MEDTECH | Interventional Solutions | International
Sales by segment of business
Sales to customers	$ 667	513	$ 2,019	1,636
Percent Change (as a percent)	29.90%		23.40%
MEDTECH | ELECTROPHYSIOLOGY
Sales by segment of business
Sales to customers	$ 1,161	973	$ 3,449	2,943
Percent Change (as a percent)	19.30%		17.20%
MEDTECH | ELECTROPHYSIOLOGY | U.S.
Sales by segment of business
Sales to customers	$ 611	520	$ 1,791	1,489
Percent Change (as a percent)	17.60%		20.30%
MEDTECH | ELECTROPHYSIOLOGY | International
Sales by segment of business
Sales to customers	$ 549	453	$ 1,658	1,454
Percent Change (as a percent)	21.20%		14.00%
MEDTECH | ABIOMED(3)
Sales by segment of business
Sales to customers	$ 311	0	$ 966	0
MEDTECH | ABIOMED(3) | U.S.
Sales by segment of business
Sales to customers	254	0	790	0
MEDTECH | ABIOMED(3) | International
Sales by segment of business
Sales to customers	57	0	176	0
MEDTECH | OTHER INTERVENTIONAL SOLUTIONS
Sales by segment of business
Sales to customers	$ 87	87	$ 267	258
Percent Change (as a percent)	(0.30%)		3.30%
MEDTECH | OTHER INTERVENTIONAL SOLUTIONS | U.S.
Sales by segment of business
Sales to customers	$ 26	27	$ 81	77
Percent Change (as a percent)	(3.20%)		5.90%
MEDTECH | OTHER INTERVENTIONAL SOLUTIONS | International
Sales by segment of business
Sales to customers	$ 61	60	$ 186	181
Percent Change (as a percent)	1.00%		2.20%
MEDTECH | Orthopaedics
Sales by segment of business
Sales to customers	$ 2,164	2,095	$ 6,674	6,440
Percent Change (as a percent)	3.40%		3.60%
MEDTECH | Orthopaedics | U.S.
Sales by segment of business
Sales to customers	$ 1,349	1,309	$ 4,100	3,936
Percent Change (as a percent)	3.10%		4.20%
MEDTECH | Orthopaedics | International
Sales by segment of business
Sales to customers	$ 815	785	$ 2,574	2,504
Percent Change (as a percent)	3.90%		2.80%
MEDTECH | Orthopaedics | HIPS
Sales by segment of business
Sales to customers	$ 375	352	$ 1,162	1,129
Percent Change (as a percent)	6.50%		2.90%
MEDTECH | Orthopaedics | HIPS | U.S.
Sales by segment of business
Sales to customers	$ 239	228	$ 730	693
Percent Change (as a percent)	4.90%		5.40%
MEDTECH | Orthopaedics | HIPS | International
Sales by segment of business
Sales to customers	$ 136	124	$ 432	437
Percent Change (as a percent)	9.30%		(1.00%)
MEDTECH | Orthopaedics | KNEES
Sales by segment of business
Sales to customers	$ 338	317	$ 1,069	1,005
Percent Change (as a percent)	6.70%		6.40%
MEDTECH | Orthopaedics | KNEES | U.S.
Sales by segment of business
Sales to customers	$ 207	203	$ 654	620
Percent Change (as a percent)	2.30%		5.60%
MEDTECH | Orthopaedics | KNEES | International
Sales by segment of business
Sales to customers	$ 131	115	$ 415	386
Percent Change (as a percent)	14.60%		7.70%
MEDTECH | Orthopaedics | TRAUMA
Sales by segment of business
Sales to customers	$ 742	717	$ 2,238	2,161
Percent Change (as a percent)	3.50%		3.50%
MEDTECH | Orthopaedics | TRAUMA | U.S.
Sales by segment of business
Sales to customers	$ 488	473	$ 1,462	1,412
Percent Change (as a percent)	3.20%		3.50%
MEDTECH | Orthopaedics | TRAUMA | International
Sales by segment of business
Sales to customers	$ 253	244	$ 775	749
Percent Change (as a percent)	4.20%		3.50%
MEDTECH | Orthopaedics | SPINE, SPORTS & OTHER
Sales by segment of business
Sales to customers	$ 710	708	$ 2,205	2,144
Percent Change (as a percent)	0.20%		2.80%
MEDTECH | Orthopaedics | SPINE, SPORTS & OTHER | U.S.
Sales by segment of business
Sales to customers	$ 415	406	$ 1,254	1,211
Percent Change (as a percent)	2.30%		3.50%
MEDTECH | Orthopaedics | SPINE, SPORTS & OTHER | International
Sales by segment of business
Sales to customers	$ 295	303	$ 952	933
Percent Change (as a percent)	(2.60%)		2.00%
MEDTECH | Surgery
Sales by segment of business
Sales to customers	$ 2,479	2,422	$ 7,507	7,306
Percent Change (as a percent)	2.30%		2.70%
MEDTECH | Surgery | U.S.
Sales by segment of business
Sales to customers	$ 994	984	$ 2,984	2,897
Percent Change (as a percent)	1.10%		3.00%
MEDTECH | Surgery | International
Sales by segment of business
Sales to customers	$ 1,483	1,439	$ 4,522	4,410
Percent Change (as a percent)	3.10%		2.60%
MEDTECH | Surgery | ADVANCED
Sales by segment of business
Sales to customers	$ 1,164	1,158	$ 3,504	3,460
Percent Change (as a percent)	0.50%		1.30%
MEDTECH | Surgery | ADVANCED | U.S.
Sales by segment of business
Sales to customers	$ 455	457	$ 1,365	1,328
Percent Change (as a percent)	(0.40%)		2.80%
MEDTECH | Surgery | ADVANCED | International
Sales by segment of business
Sales to customers	$ 709	701	$ 2,139	2,132
Percent Change (as a percent)	1.00%		0.30%
MEDTECH | Surgery | GENERAL
Sales by segment of business
Sales to customers	$ 1,314	1,264	$ 4,002	3,846
Percent Change (as a percent)	4.00%		4.10%
MEDTECH | Surgery | GENERAL | U.S.
Sales by segment of business
Sales to customers	$ 540	527	$ 1,619	1,569
Percent Change (as a percent)	2.40%		3.20%
MEDTECH | Surgery | GENERAL | International
Sales by segment of business
Sales to customers	$ 775	737	$ 2,383	2,277
Percent Change (as a percent)	5.10%		4.70%
MEDTECH | Vision
Sales by segment of business
Sales to customers	$ 1,256	1,206	$ 3,864	3,704
Percent Change (as a percent)	4.20%		4.30%
MEDTECH | Vision | U.S.
Sales by segment of business
Sales to customers	$ 512	517	$ 1,599	1,534
Percent Change (as a percent)	(1.00%)		4.20%
MEDTECH | Vision | International
Sales by segment of business
Sales to customers	$ 744	689	$ 2,265	2,170
Percent Change (as a percent)	8.10%		4.40%
MEDTECH | Vision | CONTACT LENSES / OTHER
Sales by segment of business
Sales to customers	$ 928	908	$ 2,820	2,712
Percent Change (as a percent)	2.20%		4.00%
MEDTECH | Vision | CONTACT LENSES / OTHER | U.S.
Sales by segment of business
Sales to customers	$ 399	405	$ 1,252	1,179
Percent Change (as a percent)	(1.20%)		6.20%
MEDTECH | Vision | CONTACT LENSES / OTHER | International
Sales by segment of business
Sales to customers	$ 529	503	$ 1,568	1,533
Percent Change (as a percent)	4.90%		2.30%
MEDTECH | Vision | SURGICAL
Sales by segment of business
Sales to customers	$ 328	298	$ 1,044	992
Percent Change (as a percent)	10.30%		5.30%
MEDTECH | Vision | SURGICAL | U.S.
Sales by segment of business
Sales to customers	$ 112	112	$ 346	355
Percent Change (as a percent)	(0.10%)		(2.50%)
MEDTECH | Vision | SURGICAL | International
Sales by segment of business
Sales to customers	$ 216	186	$ 698	637
Percent Change (as a percent)	16.60%		9.60%
Innovative Medicine
Sales by segment of business
Sales to customers	$ 13,893	13,214	$ 41,037	39,400
Percent Change (as a percent)	5.10%		4.20%
Innovative Medicine | U.S.
Sales by segment of business
Sales to customers	$ 8,249	7,438	$ 23,090	21,229
Percent Change (as a percent)	10.90%		8.80%
Innovative Medicine | International
Sales by segment of business
Sales to customers	$ 5,644	5,776	$ 17,947	18,171
Percent Change (as a percent)	(2.30%)		(1.20%)
Innovative Medicine | Immunology
Sales by segment of business
Sales to customers	$ 4,849	4,287	$ 13,457	12,817
Percent Change (as a percent)	13.10%		5.00%
Innovative Medicine | Immunology | U.S.
Sales by segment of business
Sales to customers	$ 3,193	2,876	$ 8,506	8,230
Percent Change (as a percent)	11.00%		3.30%
Innovative Medicine | Immunology | International
Sales by segment of business
Sales to customers	$ 1,656	1,411	$ 4,951	4,587
Percent Change (as a percent)	17.40%		7.90%
Innovative Medicine | Immunology | REMICADE
Sales by segment of business
Sales to customers	$ 461	558	$ 1,410	1,868
Percent Change (as a percent)	(17.40%)		(24.50%)
Innovative Medicine | Immunology | REMICADE | U.S.
Sales by segment of business
Sales to customers	$ 296	350	$ 849	1,099
Percent Change (as a percent)	(15.40%)		(22.70%)
Innovative Medicine | Immunology | REMICADE | U.S. Exports
Sales by segment of business
Sales to customers	$ 38	39	$ 112	163
Percent Change (as a percent)	(2.50%)		(31.30%)
Innovative Medicine | Immunology | REMICADE | International
Sales by segment of business
Sales to customers	$ 127	169	$ 449	606
Percent Change (as a percent)	(25.10%)		(25.90%)
Innovative Medicine | Immunology | SIMPONI / SIMPONI ARIA
Sales by segment of business
Sales to customers	$ 629	545	$ 1,695	1,682
Percent Change (as a percent)	15.30%		0.80%
Innovative Medicine | Immunology | SIMPONI / SIMPONI ARIA | U.S.
Sales by segment of business
Sales to customers	$ 310	298	$ 866	886
Percent Change (as a percent)	3.90%		(2.30%)
Innovative Medicine | Immunology | SIMPONI / SIMPONI ARIA | International
Sales by segment of business
Sales to customers	$ 319	248	$ 829	797
Percent Change (as a percent)	29.10%		4.10%
Innovative Medicine | Immunology | STELARA
Sales by segment of business
Sales to customers	$ 2,864	2,449	$ 8,105	7,336
Percent Change (as a percent)	16.90%		10.50%
Innovative Medicine | Immunology | STELARA | U.S.
Sales by segment of business
Sales to customers	$ 1,912	1,655	$ 5,180	4,766
Percent Change (as a percent)	15.50%		8.70%
Innovative Medicine | Immunology | STELARA | International
Sales by segment of business
Sales to customers	$ 951	794	$ 2,925	2,571
Percent Change (as a percent)	19.90%		13.80%
Innovative Medicine | Immunology | TREMFYA
Sales by segment of business
Sales to customers	$ 891	729	$ 2,237	1,916
Percent Change (as a percent)	22.20%		16.80%
Innovative Medicine | Immunology | TREMFYA | U.S.
Sales by segment of business
Sales to customers	$ 634	530	$ 1,490	1,303
Percent Change (as a percent)	19.60%		14.40%
Innovative Medicine | Immunology | TREMFYA | International
Sales by segment of business
Sales to customers	$ 258	200	$ 747	613
Percent Change (as a percent)	29.00%		21.90%
Innovative Medicine | Immunology | OTHER IMMUNOLOGY
Sales by segment of business
Sales to customers	$ 2	5	$ 9	14
Percent Change (as a percent)	(47.10%)		(36.10%)
Innovative Medicine | Immunology | OTHER IMMUNOLOGY | U.S.
Sales by segment of business
Sales to customers	$ 2	5	$ 9	14
Percent Change (as a percent)	(47.10%)		(36.10%)
Innovative Medicine | Immunology | OTHER IMMUNOLOGY | International
Sales by segment of business
Sales to customers	$ 0	0	$ 0	0
Percent Change (as a percent)	0.00%		0.00%
Innovative Medicine | Infectious Diseases
Sales by segment of business
Sales to customers	$ 859	1,295	$ 3,566	3,908
Percent Change (as a percent)	(33.60%)		(8.70%)
Innovative Medicine | Infectious Diseases | U.S.
Sales by segment of business
Sales to customers	$ 360	390	$ 1,147	1,266
Percent Change (as a percent)	(7.80%)		(9.40%)
Innovative Medicine | Infectious Diseases | International
Sales by segment of business
Sales to customers	$ 500	905	$ 2,420	2,642
Percent Change (as a percent)	(44.80%)		(8.40%)
Innovative Medicine | Infectious Diseases | COVID-19
Sales by segment of business
Sales to customers	$ 41	489	$ 1,073	1,490
Percent Change (as a percent)	(91.50%)		(27.90%)
Innovative Medicine | Infectious Diseases | COVID-19 | U.S.
Sales by segment of business
Sales to customers	$ 0	0	$ 0	120
Innovative Medicine | Infectious Diseases | COVID-19 | International
Sales by segment of business
Sales to customers	$ 41	489	$ 1,073	1,370
Percent Change (as a percent)	(91.50%)		(21.60%)
Innovative Medicine | Infectious Diseases | EDURANT / rilpivirine
Sales by segment of business
Sales to customers	$ 297	245	$ 843	718
Percent Change (as a percent)	21.00%		17.50%
Innovative Medicine | Infectious Diseases | EDURANT / rilpivirine | U.S.
Sales by segment of business
Sales to customers	$ 9	9	$ 26	27
Percent Change (as a percent)	10.20%		(0.50%)
Innovative Medicine | Infectious Diseases | EDURANT / rilpivirine | International
Sales by segment of business
Sales to customers	$ 287	237	$ 816	691
Percent Change (as a percent)	21.40%		18.20%
Innovative Medicine | Infectious Diseases | PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA
Sales by segment of business
Sales to customers	$ 447	485	$ 1,415	1,450
Percent Change (as a percent)	(7.80%)		(2.40%)
Innovative Medicine | Infectious Diseases | PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA | U.S.
Sales by segment of business
Sales to customers	$ 345	372	$ 1,105	1,096
Percent Change (as a percent)	(7.30%)		0.90%
Innovative Medicine | Infectious Diseases | PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA | International
Sales by segment of business
Sales to customers	$ 102	112	$ 310	354
Percent Change (as a percent)	(9.50%)		(12.50%)
Innovative Medicine | Infectious Diseases | OTHER INFECTIOUS DISEASES(
Sales by segment of business
Sales to customers	$ 74	77	$ 235	251
Percent Change (as a percent)	(3.60%)		(6.40%)
Innovative Medicine | Infectious Diseases | OTHER INFECTIOUS DISEASES( | U.S.
Sales by segment of business
Sales to customers	$ 5	10	$ 15	24
Percent Change (as a percent)	(42.70%)		(35.50%)
Innovative Medicine | Infectious Diseases | OTHER INFECTIOUS DISEASES( | International
Sales by segment of business
Sales to customers	$ 69	68	$ 220	228
Percent Change (as a percent)	2.00%		(3.40%)
Innovative Medicine | Neuroscience
Sales by segment of business
Sales to customers	$ 1,742	1,681	$ 5,339	5,156
Percent Change (as a percent)	3.60%		3.50%
Innovative Medicine | Neuroscience | U.S.
Sales by segment of business
Sales to customers	$ 1,036	919	$ 3,043	2,658
Percent Change (as a percent)	12.70%		14.50%
Innovative Medicine | Neuroscience | International
Sales by segment of business
Sales to customers	$ 706	763	$ 2,296	2,498
Percent Change (as a percent)	(7.40%)		(8.10%)
Innovative Medicine | Neuroscience | CONCERTA / methylphenidate
Sales by segment of business
Sales to customers	$ 189	158	$ 603	476
Percent Change (as a percent)	20.00%		26.70%
Innovative Medicine | Neuroscience | CONCERTA / methylphenidate | U.S.
Sales by segment of business
Sales to customers	$ 57	41	$ 191	114
Percent Change (as a percent)	38.10%		67.40%
Innovative Medicine | Neuroscience | CONCERTA / methylphenidate | International
Sales by segment of business
Sales to customers	$ 133	117	$ 412	362
Percent Change (as a percent)	13.60%		13.80%
Innovative Medicine | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA
Sales by segment of business
Sales to customers	$ 1,029	1,031	$ 3,104	3,132
Percent Change (as a percent)	(0.20%)		(0.90%)
Innovative Medicine | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA | U.S.
Sales by segment of business
Sales to customers	$ 730	684	$ 2,164	2,036
Percent Change (as a percent)	6.80%		6.30%
Innovative Medicine | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA | International
Sales by segment of business
Sales to customers	$ 299	348	$ 940	1,097
Percent Change (as a percent)	(14.00%)		(14.30%)
Innovative Medicine | Neuroscience | SPRAVATO
Sales by segment of business
Sales to customers	$ 183	100	$ 483	255
Percent Change (as a percent)	82.10%		88.80%
Innovative Medicine | Neuroscience | SPRAVATO | U.S.
Sales by segment of business
Sales to customers	$ 154	88	$ 409	223
Percent Change (as a percent)	75.10%		83.10%
Innovative Medicine | Neuroscience | SPRAVATO | International
Sales by segment of business
Sales to customers	$ 29	12	$ 74	32
Innovative Medicine | Neuroscience | OTHER NEUROSCIENCE
Sales by segment of business
Sales to customers	$ 340	393	$ 1,149	1,293
Percent Change (as a percent)	(13.20%)		(11.00%)
Innovative Medicine | Neuroscience | OTHER NEUROSCIENCE | U.S.
Sales by segment of business
Sales to customers	$ 94	106	$ 278	285
Percent Change (as a percent)	(11.30%)		(2.30%)
Innovative Medicine | Neuroscience | OTHER NEUROSCIENCE | International
Sales by segment of business
Sales to customers	$ 245	286	$ 870	1,007
Percent Change (as a percent)	(13.90%)		(13.50%)
Innovative Medicine | Oncology
Sales by segment of business
Sales to customers	$ 4,533	4,064	$ 13,043	12,056
Percent Change (as a percent)	11.50%		8.20%
Innovative Medicine | Oncology | U.S.
Sales by segment of business
Sales to customers	$ 2,219	1,812	$ 6,177	5,073
Percent Change (as a percent)	22.50%		21.80%
Innovative Medicine | Oncology | International
Sales by segment of business
Sales to customers	$ 2,313	2,252	$ 6,865	6,983
Percent Change (as a percent)	2.70%		(1.70%)
Innovative Medicine | Oncology | CARVYKTI
Sales by segment of business
Sales to customers	$ 152	55	$ 341	79
Innovative Medicine | Oncology | CARVYKTI | U.S.
Sales by segment of business
Sales to customers	140	55	324	79
Innovative Medicine | Oncology | CARVYKTI | International
Sales by segment of business
Sales to customers	12	0	17	0
Innovative Medicine | Oncology | DARZALEX
Sales by segment of business
Sales to customers	$ 2,499	2,052	$ 7,194	5,894
Percent Change (as a percent)	21.80%		22.10%
Innovative Medicine | Oncology | DARZALEX | U.S.
Sales by segment of business
Sales to customers	$ 1,369	1,097	$ 3,882	3,071
Percent Change (as a percent)	24.80%		26.40%
Innovative Medicine | Oncology | DARZALEX | International
Sales by segment of business
Sales to customers	$ 1,130	955	$ 3,312	2,823
Percent Change (as a percent)	18.30%		17.30%
Innovative Medicine | Oncology | ERLEADA
Sales by segment of business
Sales to customers	$ 631	490	$ 1,740	1,340
Percent Change (as a percent)	28.70%		29.80%
Innovative Medicine | Oncology | ERLEADA | U.S.
Sales by segment of business
Sales to customers	$ 288	254	$ 778	693
Percent Change (as a percent)	12.90%		12.20%
Innovative Medicine | Oncology | ERLEADA | International
Sales by segment of business
Sales to customers	$ 342	235	$ 961	647
Percent Change (as a percent)	45.80%		48.70%
Innovative Medicine | Oncology | IMBRUVICA
Sales by segment of business
Sales to customers	$ 808	911	$ 2,476	2,918
Percent Change (as a percent)	(11.30%)		(15.20%)
Innovative Medicine | Oncology | IMBRUVICA | U.S.
Sales by segment of business
Sales to customers	$ 264	353	$ 796	1,072
Percent Change (as a percent)	(25.20%)		(25.80%)
Innovative Medicine | Oncology | IMBRUVICA | International
Sales by segment of business
Sales to customers	$ 545	559	$ 1,681	1,847
Percent Change (as a percent)	(2.50%)		(9.00%)
Innovative Medicine | Oncology | ZYTIGA / abiraterone acetate
Sales by segment of business
Sales to customers	$ 214	456	$ 686	1,500
Percent Change (as a percent)	(53.00%)		(54.20%)
Innovative Medicine | Oncology | ZYTIGA / abiraterone acetate | U.S.
Sales by segment of business
Sales to customers	$ 16	16	$ 41	54
Percent Change (as a percent)	(2.80%)		(24.90%)
Innovative Medicine | Oncology | ZYTIGA / abiraterone acetate | International
Sales by segment of business
Sales to customers	$ 199	440	$ 646	1,446
Percent Change (as a percent)	(54.90%)		(55.30%)
Innovative Medicine | Oncology | OTHER ONCOLOGY
Sales by segment of business
Sales to customers	$ 229	100	$ 605	324
Percent Change (as a percent)			86.50%
Innovative Medicine | Oncology | OTHER ONCOLOGY | U.S.
Sales by segment of business
Sales to customers	143	37	$ 357	104
Innovative Medicine | Oncology | OTHER ONCOLOGY | International
Sales by segment of business
Sales to customers	$ 86	64	$ 248	220
Percent Change (as a percent)	34.50%		12.50%
Innovative Medicine | Pulmonary Hypertension
Sales by segment of business
Sales to customers	$ 954	852	$ 2,798	2,547
Percent Change (as a percent)	12.00%		9.90%
Innovative Medicine | Pulmonary Hypertension | U.S.
Sales by segment of business
Sales to customers	$ 680	604	$ 1,964	1,736
Percent Change (as a percent)	12.60%		13.10%
Innovative Medicine | Pulmonary Hypertension | International
Sales by segment of business
Sales to customers	$ 274	247	$ 835	810
Percent Change (as a percent)	10.50%		3.00%
Innovative Medicine | Pulmonary Hypertension | OPSUMIT
Sales by segment of business
Sales to customers	$ 490	441	$ 1,437	1,322
Percent Change (as a percent)	11.20%		8.70%
Innovative Medicine | Pulmonary Hypertension | OPSUMIT | U.S.
Sales by segment of business
Sales to customers	$ 323	289	$ 924	827
Percent Change (as a percent)	12.20%		11.80%
Innovative Medicine | Pulmonary Hypertension | OPSUMIT | International
Sales by segment of business
Sales to customers	$ 166	152	$ 512	495
Percent Change (as a percent)	9.30%		3.50%
Innovative Medicine | Pulmonary Hypertension | UPTRAVI
Sales by segment of business
Sales to customers	$ 402	333	$ 1,163	986
Percent Change (as a percent)	20.70%		18.00%
Innovative Medicine | Pulmonary Hypertension | UPTRAVI | U.S.
Sales by segment of business
Sales to customers	$ 336	283	$ 978	824
Percent Change (as a percent)	18.90%		18.70%
Innovative Medicine | Pulmonary Hypertension | UPTRAVI | International
Sales by segment of business
Sales to customers	$ 66	50	$ 185	162
Percent Change (as a percent)	30.90%		14.10%
Innovative Medicine | Pulmonary Hypertension | Other
Sales by segment of business
Sales to customers	$ 63	78	$ 199	239
Percent Change (as a percent)	(19.80%)		(16.90%)
Innovative Medicine | Pulmonary Hypertension | Other | U.S.
Sales by segment of business
Sales to customers	$ 20	33	$ 61	86
Percent Change (as a percent)	(37.10%)		(28.40%)
Innovative Medicine | Pulmonary Hypertension | Other | International
Sales by segment of business
Sales to customers	$ 42	46	$ 137	154
Percent Change (as a percent)	(7.50%)		(10.50%)
Innovative Medicine | Cardiovascular / Metabolism / Other
Sales by segment of business
Sales to customers	$ 957	1,034	$ 2,834	2,916
Percent Change (as a percent)	(7.50%)		(2.80%)
Innovative Medicine | Cardiovascular / Metabolism / Other | U.S.
Sales by segment of business
Sales to customers	$ 763	837	$ 2,254	2,266
Percent Change (as a percent)	(8.80%)		(0.50%)
Innovative Medicine | Cardiovascular / Metabolism / Other | International
Sales by segment of business
Sales to customers	$ 194	198	$ 580	651
Percent Change (as a percent)	(2.10%)		(10.80%)
Innovative Medicine | Cardiovascular / Metabolism / Other | Other
Sales by segment of business
Sales to customers	$ 332	345	$ 994	1,110
Percent Change (as a percent)	(3.80%)		(10.50%)
Innovative Medicine | Cardiovascular / Metabolism / Other | Other | U.S.
Sales by segment of business
Sales to customers	$ 139	147	$ 414	459
Percent Change (as a percent)	(6.10%)		(9.90%)
Innovative Medicine | Cardiovascular / Metabolism / Other | Other | International
Sales by segment of business
Sales to customers	$ 194	198	$ 580	651
Percent Change (as a percent)	(2.10%)		(10.80%)
Innovative Medicine | Cardiovascular / Metabolism / Other | XARELTO
Sales by segment of business
Sales to customers	$ 625	689	$ 1,840	1,806
Percent Change (as a percent)	(9.40%)		1.90%
Innovative Medicine | Cardiovascular / Metabolism / Other | XARELTO | U.S.
Sales by segment of business
Sales to customers	$ 625	689	$ 1,840	1,806
Percent Change (as a percent)	(9.40%)		1.90%
Innovative Medicine | Cardiovascular / Metabolism / Other | XARELTO | International
Sales by segment of business
Sales to customers	$ 0	$ 0	$ 0	$ 0
Percent Change (as a percent)	0.00%		0.00%